Skip to main content
. Author manuscript; available in PMC: 2012 Apr 1.
Published in final edited form as: J Biosci Bioeng. 2011 Jan 8;111(4):383–387. doi: 10.1016/j.jbiosc.2010.12.008

Fig 2. Male DR.lepr-/lepr- rats receiving encapsulated VSMC secreting GLP-1 after onset of diabetes.

Fig 2

Treated (closed colored symbols) and untreated (black open symbols) rats were monitored for blood glucose (A) and weight (B). After diabetes onset two rats received implants at 64 days of age (red symbols, red arrow) and one at 73 days of age (blue symbol, blue arrow). Theracyte implants were removed from two rats at 91 days of age (black arrow head) and subsequent blood glucose and weights are shown as open colored symbols.